Barclays (BARC.L) witnessed a drop in its shares during early trading on Tuesday following a significant move by one of the bank’s major shareholders, Qatar Holding, to sell approximately £510 million ($644
MoreChina Evergrande Group (3333.HK) has successfully secured an adjournment for a court hearing regarding a liquidation petition until January 29th, providing the troubled property developer with additional time to finalize an overhauled
MorePetrofac (PFC.L) announced on Monday that it is currently in discussions regarding the potential sale of certain non-core assets. Simultaneously, the company cautioned that it would no longer be able to achieve
MoreSouthwest Airlines (LUV.N) and its pilots’ union are reportedly on the verge of finalizing a new labor agreement, just in time for the holiday season, according to an insider familiar with the
MoreOn Monday, Bitcoin experienced a significant surge, briefly surpassing the $42,000 mark and reaching its highest point in 20 months. This sudden momentum can be attributed to growing expectations of a U.S.
MoreWalmart (WMT.N) announced on Friday that it has joined the growing list of brands that are no longer advertising on the social media platform known as “X,” previously recognized as Twitter. A
MoreA U.S. judge has ruled that Donald Trump is not immune from criminal charges related to his actions during his presidency. This decision, issued by U.S. District Judge Tanya Chutkan, rejects Trump’s
MoreA Delaware judge has announced her willingness to grant a January trial request made by Warren Buffett’s Berkshire Hathaway, under certain conditions, to settle allegations that billionaire Jimmy Haslam attempted to improperly
MoreThe Biden administration has unveiled a set of final regulations designed to address methane emissions from the U.S. oil and gas industry, as part of a global effort to combat climate change.
MorePfizer (PFE.N) made a significant announcement on Friday, revealing that it would not be advancing a twice-daily version of the oral weight-loss drug danuglipron into late-stage studies. This decision came after a
More
